XML 39 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue    
Research and development revenue under collaboration agreement $ 30,985 $ 9,194
Revenue from Contract with Customer, Product and Service [Extensible List] Research And Development Member Research And Development Member
Operating expenses    
Research and development $ 47,108 $ 44,847
General and administrative 18,015 8,866
Total operating expenses 65,123 53,713
Loss from operations (34,138) (44,519)
Other income, net 23 263
Net loss and comprehensive loss $ (34,115) $ (44,256)
Net loss per share attributable to common stockholders, basic and diluted $ (1.22) $ (16.00)
Weighted-average shares of common stock outstanding, basic and diluted 27,983,359 2,765,494